Cinclus Pharma Holding AB (OSTO:CINPHA) Other Operating Expense : kr0.71 Mil (TTM As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Cinclus Pharma Holding AB Other Operating Expense?

Cinclus Pharma Holding AB's Other Operating Expense for the three months ended in Dec. 2024 was kr0.84 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 was kr0.71 Mil.

Cinclus Pharma Holding AB's quarterly Other Operating Expense increased from Jun. 2024 (kr-0.17 Mil) to Sep. 2024 (kr-0.15 Mil) and increased from Sep. 2024 (kr-0.15 Mil) to Dec. 2024 (kr0.84 Mil).

Cinclus Pharma Holding AB's annual Other Operating Expense stayed the same from Dec. 2022 (kr0.00 Mil) to Dec. 2023 (kr0.00 Mil) and stayed the same from Dec. 2023 (kr0.00 Mil) to Dec. 2024 (kr0.00 Mil).

Cinclus Pharma Holding AB Other Operating Expense Historical Data

The historical data trend for Cinclus Pharma Holding AB's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cinclus Pharma Holding AB Other Operating Expense Chart

Cinclus Pharma Holding AB Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Other Operating Expense

Cinclus Pharma Holding AB Quarterly Data
	Dec21	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Other Operating Expense	Get a 7-Day Free Trial					0.30	0.18	-0.17	-0.15	0.84

Cinclus Pharma Holding AB Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.71 Mil.

Cinclus Pharma Holding AB Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Cinclus Pharma Holding AB's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Cinclus Pharma Holding AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cinclus Pharma Holding AB (OSTO:CINPHA) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

J8P:Germany

Address

Kungsbron 1, Stockholm, SWE, SE-111 22

Website

https://www.cincluspharma.com

Cinclus Pharma Holding AB is a clinical stage pharmaceutical company developing a drug for the treatment of erosive gastroesophageal reflux diseases, and a dual therapy treatment with an antibiotic targeting Helicobacter pylori which is a bacteria that occurs in the gastric and duodenal mucosa. The Company's main target population is patients suffering from severe eGERD, where there is a lack of satisfactory treatment options.

Cinclus Pharma Holding AB Headlines

No Headlines